Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

NCT00598832 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1075
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Galderma R&D